Guest guest Posted May 10, 2006 Report Share Posted May 10, 2006 I don't know about Forteo but I take Evista for the same reason (because I can't tolerate the other stuff Actenol and Fosomax) and I have had no side effects to date. Take Care Babs Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 11, 2006 Report Share Posted May 11, 2006 I have been on Enbrel for several years and have had absolutely no adverse side effects. It is working very well for me. In fact, my recent C-reactive Protein, which measures inflammation in the body, was 0.0. I urge her to try the Enbrel. If she has bad side effects, she can always discontinue it. Sue On Wednesday, May 10, 2006, at 02:07 PM, Sears wrote: > Because that combination doesn't seem to be controlling her RA, her > rheumy just recently prescribed Enbrel to be added to the other > medications. She has not yet started it pending insurance approval. > It is difficult to ignore the possible side effects from it and gather > the courage to add this medicine, even though we have read how it has > helped so many here. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 11, 2006 Report Share Posted May 11, 2006 Thank you so much, Sue, for your response. Sometimes, the right words at just the right time make all the difference in the world. Thanks again. > > > Because that combination doesn't seem to be controlling her RA, her > > rheumy just recently prescribed Enbrel to be added to the other > > medications. She has not yet started it pending insurance approval. > > It is difficult to ignore the possible side effects from it and gather > > the courage to add this medicine, even though we have read how it has > > helped so many here. > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.